cassavasciences.com (SAVA) - Uzoq muddatli majburiyatlarning kapitalga nisbati
Uzoq muddatli majburiyatlarning kapitaldagi ulushi Cassava Sciences, Inc. (SAVA) moliyaviy barqarorligini ko'rsatadi, bunda 0.00 ko'rsatkichi maqsadli daraja vazifasini o'taydi. O'sish istiqbollari Altsgeymer kasalligini davolash uchun mo'ljallangan va sezilarli narx belgilash imkoniyatini beruvchi Simufilam dori vositasiga asoslangan. Kompaniya biomateriallarning energiyatejamkor saqlash tizimini va kimyoviy moddalarni xavfsiz utilizatsiya qilishni joriy etmoqda, shu bilan birga, dorining tajriba partiyalarini ishlab chiqarish uchun tahliliy markazlarni modernizatsiya qilmoqda.
&width=1200&height=400&colorIndex=0&v=mvx9zauv.4e-7b561vk&start=20220704&end=20261101&filename=GURU_Markets_-_SAVA_-_Cassava-Sciences-Inc._-_Long-Term-Debt-to-Equity-Ratio "SAVA - Cassava Sciences Uzoq muddatli qarzning kapitalga nisbati 04.07.2022 - 11.03.2026 oraligʻida | 👁️GURU.Markets👁️")
Cassava Sciences, Inc. (SAVA) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil
- joriy narx va aksiyalarning prognoz qilingan qiymati:
- bozor kapitallashuvi ko'rsatkichlari:
- xususiy kapitalning balans qiymati ko'rsatkichlari:
- qarz majburiyatlari va likvidlik statistikasi:
Qarzning kapitalga nisbati Cassava Sciences, Inc.|SAVA - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli qarzning o'z kapitaliga nisbati cassavasciences.com|SAVA - Kompaniyaning jamlangan qarzlari|Balans kapitallashuviga qarzlar Cassava Sciences, Inc.|SAVA - Kompaniyaning uzoq muddatli qarzi|Qisqa muddatli qarz hajmi Cassava Sciences|Oraliq qoplama koeffitsiyenti cassavasciences.com
- sof foyda va baholash koeffitsiyentlari ma'lumotlari:
Kompaniyaning jamlanma tahlili:SAVA, Cassava Sciences Inc
Cassava Sciences, Inc. (SAVA) uchun uzoq muddatli majburiyatlar va kapital o'rtasidagi muvozanat Altsgeymer kasalligi bo'yicha tadqiqotlarining moliyaviy barqarorligini belgilaydi. Ushbu uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi bir yildan ortiq muddatga ega bo'lgan kreditlarning umumiy kapitalga nisbati sifatida hisoblanadi. Ushbu metrikaning oshishi moliyaviy xatarlarning ortishidan dalolat beradi. Qarz yuklamasining pastligi olimlarga byurokratiyasiz faoliyat yuritish imkonini beradi. Ushbu metrikaning barqarorligi kompaniyaning keng ko'lamli tadqiqotlarni davom ettirish qobiliyatini tasdiqlaydi.
Raqobatdosh kompaniyalar tahlili
Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi BIIB (Biogen Inc)|Uzoq muddatli qarzning kapitalga nisbati NBIX|RGC - Uzoq muddatli majburiyatlarning kapitalga nisbati|Axsome Therapeutics - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati acadia-pharm.com ACAD|XENE - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti VKTX (Viking Therapeutics Inc)|Supernus Pharma (SUPN) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Catalyst Corp (CPRX)|DNLI (Denali Therapeutics) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati harmonybiosciences.com (HRMY)|Uzoq muddatli qarzning kapitalga nisbati BHVN|Uzoq muddatli qarzning kapitalga nisbati Amylyx Pharmaceuticals Inc (AMLX)|Uzoq muddatli qarzning o'z kapitaliga nisbati Trevi Pharma TRVI|Uzoq muddatli qarzdorlikning kapitalga nisbati Praxis Corp (PRAX)|AVXL - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzdorlikning kapitalga nisbati ceribell.com CBLL|PRTA: Uzoq muddatli qarzning kapitalga nisbati|Alector (ALEC) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati ANNX|Uzoq muddatli qarzning o'z kapitaliga nisbati OMER|Uzoq muddatli qarzning kapitalga nisbati NGNE|Uzoq muddatli qarzning kapitalga nisbati acimmune.com (ACIU)|Voyager Therapeutics, Inc. - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti NMRA|SCLX - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzdorlikning kapitalga nisbati Tevogen Bio Inc. TVGN|ACOG: Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati cogrx.com|IKT (Inhibikase Therapeutics, Inc.) - Uzoq muddatli qarzning kapitalga nisbati|Assertio Therapeutics (ASRT) - Uzoq muddatli qarzdorlikning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati COYA|VTGN - Uzoq muddatli majburiyatlarning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Ovid Therapeutics OVID|ABOS: Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|CervoMed - Uzoq muddatli qarzning kapitalga nisbati|Alterity Therapeutics (ATHE) - Uzoq muddatli qarzning o'z kapitaliga nisbati|CLNN: Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati PepGen (PEPG)|Uzoq muddatli qarzning o'z kapitaliga nisbati Jupiter Neurosciences Inc|relmada.com (RLMD) - Uzoq muddatli qarzdorlikning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati ANVS (Annovis Bio)|GRCE (gracetx.com) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati AIFF (Firefly Neuroscience Inc)|Uzoq muddatli qarzdorlikning kapitalga nisbati ANEW Medical (KLTO)|NRSN - Uzoq muddatli qarzning o'z kapitaliga nisbati|RVPH (revivapharma.com) - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|MTVA: Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati NeurAxis Inc.|Uzoq muddatli qarzning o'z kapitaliga nisbati HSDT|Passage Bio Corp (PASG) - Uzoq muddatli qarzdorlikning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Neuphoria Therapeutics Inc. (NEUP)|Uzoq muddatli qarzdorlikning kapitalga nisbati minervaneurosciences.com|Uzoq muddatli qarzning kapitalga nisbati ATHA (Athira Pharma)|Uzoq muddatli qarzning kapitalga nisbati Addex Therapeutics Ltd. ADXN|ALZN: Uzoq muddatli qarzning o'z kapitaliga nisbati|CYCN: Uzoq muddatli qarzning o'z kapitaliga nisbati|PTIX: Uzoq muddatli qarzning kapitalga nisbati|Pasithea Therapeutics Corp. (KTTA) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Cortigent Inc|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi ATXI (Avenue Therapeutics Inc.)|Uzoq muddatli qarzning kapitalga nisbati BCLI|CARA - Uzoq muddatli majburiyatlarning kapitalga nisbati|Chromocell Therapeutics - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati Eliem Therapeutics, Inc. ELYM|ITCI - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti LBPH (Longboard Pharmaceuticals Inc)|Marinus (MRNS) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati NKGen Biotech Corp (NKGN)|NRBO (NeuroBo Pharmaceuticals) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati sagerx.com (SAGE)|Uzoq muddatli qarzning kapitalga nisbati SNPX|Uzoq muddatli qarzning kapitalga nisbati Trevena Inc. (TRVN)|Uzoq muddatli qarzning o'z kapitaliga nisbati Vigil Neuroscience, Inc. VIGL|Uzoq muddatli qarzdorlikning kapitalga nisbati Anew Medical Inc. (WENA)|CERE - Uzoq muddatli qarzning o'z kapitaliga nisbati